Edwards Lifesciences (EW) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 8, 2025, at 10:00 a.m. Pacific Time, online; stockholders of record as of March 11, 2025, are eligible to vote.

• The board recommends voting FOR all proposals.

Voting matters and shareholder proposals

• Ballot includes nine director elections, an advisory vote on named executive officer compensation, auditor ratification, and amendments to the U.S. and international employee stock purchase plans.

Board of directors and corporate governance

• Nine director nominees: Leslie C. Davis, David T. Feinberg, Kieran T. Gallahue, Leslie S. Heisz, Paul A. LaViolette, Steven R. Loranger, Ramona Sequeira, Nicholas J. Valeriani, and Bernard J. Zovighian.